Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy

por Tan, Shirong, Fu, Xin, Xu, Shouping, Qiu, Pengfei, Lv, Zhidong, Xu, Yingying, Zhang, Qiang
Publicado 2021

p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells

por Jiang, Dandan, Song, Yuhua, Cao, Weihong, Wang, Xingang, Jiang, Danni, Lv, Zhidong, Yang, Zhaochuan, Li, Funian
Publicado 2019

Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study

por Yao, Litong, Liu, Xiaoyan, Wang, Mozhi, Yu, Keda, Xu, Shouping, Qiu, Pengfei, Lv, Zhidong, Zhang, Xinwen, Xu, Yingying
Publicado 2023

Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study

por Chen, Yuhai, Liu, Xiaoyan, Yu, Keda, Sun, Xiangyu, Xu, Shouping, Qiu, Pengfei, Lv, Zhidong, Zhang, Xinwen, Guo, Ayao, Xu, Yingying
Publicado 2022